The Scientist

» genetic testing

Most Recent

image: 23andMe Expands to U.K.

23andMe Expands to U.K.

By | December 2, 2014

British consumers can buy the genetic testing-associated health prediction service forbidden by the US government.

1 Comment

image: Snakebites Get DNA Fingerprint Treatment

Snakebites Get DNA Fingerprint Treatment

By | November 4, 2014

Researchers have developed a technique for determining the species of snake responsible for a bite by sequencing genetic material from the fang marks.

0 Comments

image: Australian Court Upholds Patents on Human Genes

Australian Court Upholds Patents on Human Genes

By | September 8, 2014

The Federal Court of Australia rejected an appeal of a ruling that allows companies to patent isolated human genes.

0 Comments

image: Patent Plea Ping Pong

Patent Plea Ping Pong

By | August 21, 2014

A genetic testing firm accused of infringing upon Myriad Genetics’s gene patents fights back in an attempt to wipe other patents out.

1 Comment

image: DNA Ancestry for All

DNA Ancestry for All

By | July 10, 2014

Big ad campaigns and celebrity involvement have helped increase public interest in genetic genealogy, but helping consumers understand their DNA ancestry testing results remains difficult.

2 Comments

image: Speaking of Science

Speaking of Science

By | January 1, 2014

January 2014's selection of notable quotes

0 Comments

image: The Right to Know—or Not

The Right to Know—or Not

By | December 12, 2013

Consumers, patients, and study participants should be made aware of potential incidental findings, according to a federally-appointed bioethics panel.

0 Comments

image: 23andMe Now Facing Lawsuit

23andMe Now Facing Lawsuit

By | December 4, 2013

Shortly after getting in trouble with the Food and Drug Administration, the personal genetic testing company is slapped with a class action lawsuit.

8 Comments

image: FDA to 23andMe: Stop Marketing Kits

FDA to 23andMe: Stop Marketing Kits

By | November 26, 2013

The US Food and Drug Administration blocks the marketing of unapproved genetic tests.  

9 Comments

image: Pharmacogenetics Puzzle

Pharmacogenetics Puzzle

By | November 20, 2013

Conflicting clinical trial results leave researchers unsure whether genetic information is useful for determining initial Warfarin dosage.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS